OmniMSC-AMI

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameOmniMSC-AMI
Drug Alias NameOmniMSC
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTaiwan Bio Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaiwan Bio Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A